Vitamin D and chronic obstructive pulmonary disease: hype or reality? (Q38181709)

30 August 2017

Vitamin D and chronic obstructive pulmonary disease: hype or reality? (English)

1 reference

chronic obstructive pulmonary disease

30 August 2017

0 references

1 reference

2

Marc Decramer

1 reference

30 August 2017

3

Chantal Mathieu

1 reference

30 August 2017

Wim Janssens

1

1 reference

PubMed ID

24461760

30 August 2017

Hannelie Korf

series ordinal

4

1 reference

30 August 2017

24 June 2013

1 reference

The Lancet. Respiratory medicine

30 August 2017

1 reference

30 August 2017

1

1 reference

30 August 2017

804-812

1 reference

30 August 2017

10

1 reference

High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial.

30 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Relationship of vitamin D status to adult lung function and COPD

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Vitamin D: modulator of the immune system.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Vitamin D deficiency as a risk factor for childhood allergic disease and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Analyses of associations with asthma in four asthma population samples from Canada and Australia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

1 reference

7 January 2021

The 2011 report on dietary reference intakes for calcium and vitamin D

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Vitamin D deficiency, smoking, and lung function in the Normative Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Chronic obstructive pulmonary disease is associated with low levels of vitamin D.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Serum vitamin D in patients with chronic obstructive lung disease does not correlate with mortality--results from a 10-year prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Vitamin D status and longitudinal lung function decline in the Lung Health Study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Candidate genes for COPD in two large data sets

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Severe vitamin D deficiency: a biomarker of exacerbation risk?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

A Reverse J-Shaped Association of All-Cause Mortality with Serum 25-Hydroxyvitamin D in General Practice: The CopD Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Vitamin d and susceptibility of chronic lung diseases: role of epigenetics

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Role of HDAC2 in the pathophysiology of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Decreased histone deacetylase activity in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Immunologic aspects of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

1,25-Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

The vitamin D analog, TX527, promotes a human CD4+CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Effect of 1,25-(OH)2D3 (a vitamin D analogue) on passively sensitized human airway smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Vitamin D modulates airway smooth muscle function in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

COPD exacerbations: defining their cause and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Infection in the pathogenesis and course of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Salmonella enterica serovar Typhimurium periplasmic superoxide dismutases SodCI and SodCII are required for protection against the phagocyte oxidative burst

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Vitamin D and human health: lessons from vitamin D receptor null mice.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Defective macrophage phagocytosis of bacteria in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Inhibition of vitamin d receptor translocation by cigarette smoking extracts

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Deletion of vitamin D receptor leads to premature emphysema/COPD by increased matrix metalloproteinases and lymphoid aggregates formation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

COPD as a disease of accelerated lung aging

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

1 reference

7 January 2021

SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Glucocorticoid resistance in inflammatory diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor partnership

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Vitamin D and responses to inhaled fluticasone in severe chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Can we delay the accelerated lung aging in COPD? Anti-aging molecules and interventions

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Vitamin D deficiency causes deficits in lung function and alters lung structure

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Severe vitamin D deficiency: a prerequisite for COPD responsiveness to vitamin D supplementation?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

The effect of oral and parenteral vitamin D supplementation in the elderly: a prospective, double-blinded, randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

TEI-A00114: a new vitamin D3 analogue that inhibits neutrophil recruitment in an acute lung injury hamster model while showing reduced hypercalcemic activity.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

IOM endorses vitamin D, calcium only for bone health, dispels deficiency claims

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

COPD, bone metabolism, and osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970102-4

7 January 2021

10.1016/S2213-2600(13)70102-4

Identifiers

DOI

1 reference

30 August 2017

1 reference

PubMed ID

24461760